Which treatment should patients with high-risk T1G3 bladder cancer receive?

Affiliations

¹ Keck School of Medicine, Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90089, USA. georgejh@usc.edu

Comment

George J Huang et al. Nat Clin Pract Urol. 2008 Aug.

. 2008 Aug;5(8):414-5.

doi: 10.1038/ncpuro1149. Epub 2008 Jun 24.

¹ Keck School of Medicine, Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90089, USA. georgejh@usc.edu

No abstract available

Comment on

Optimal management of high-risk T1G3 bladder cancer: a decision analysis.
Kulkarni GS, Finelli A, Fleshner NE, Jewett MA, Lopushinsky SR, Alibhai SM. Kulkarni GS, et al. PLoS Med. 2007 Sep;4(9):e284. doi: 10.1371/journal.pmed.0040284. PLoS Med. 2007. PMID: 17896857 Free PMC article.

Clinical outcome of chemoradiotherapy for T1G3 bladder cancer.
Inoue M, Ishioka J, Fukuda H, Kageyama Y, Saito Y, Higashi Y. Inoue M, et al. Int J Urol. 2008 Aug;15(8):747-50. doi: 10.1111/j.1442-2042.2008.02077.x. Int J Urol. 2008. PMID: 18786198
Management of the first recurrence of T1G3 bladder cancer: does intravesical chemotherapy deserve a chance?
Witjes JA. Witjes JA. Urol Oncol. 2009 May-Jun;27(3):322-4. doi: 10.1016/j.urolonc.2008.10.027. Urol Oncol. 2009. PMID: 19414122
Multiplicity and history have a detrimental effect on survival of patients with T1G3 bladder tumors selected for conservative treatment.
Serretta V, Ruggirello A, Dispensa N, Allegro R, Aragona F, Melloni D. Serretta V, et al. J Urol. 2008 Sep;180(3):886-90; discussion 891. doi: 10.1016/j.juro.2008.05.013. Epub 2008 Jul 17. J Urol. 2008. PMID: 18635223
[Management of Ta, T1, and in situ bladder carcinoma: what is new?].
Irani J. Irani J. Prog Urol. 2008 May;18 Suppl 5:S94-8. doi: 10.1016/S1166-7087(08)72484-9. Prog Urol. 2008. PMID: 18585634 Review. French.
The risk and prophylactic management of bladder cancer after various forms of radiotherapy.
Shirodkar SP, Kishore TA, Soloway MS. Shirodkar SP, et al. Curr Opin Urol. 2009 Sep;19(5):500-3. doi: 10.1097/MOU.0b013e32832eb3b3. Curr Opin Urol. 2009. PMID: 19553822 Review.